Guoping Wang
Impact in
- Organic Chemistry top 5%
- Asymmetric Synthesis and Catalysis
- Multicomponent Synthesis of Heterocycles
- Catalytic C–H Functionalization Methods
- Synthesis and biological activity
- Click Chemistry and Applications
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
- Oncology 8
- Cancer-related Molecular Pathways 3
- Co-authors
- Shaomeng Wang (4 shared papers)Zaneta Nikolovska‐Coleska (4 shared papers)Sanjeev Shangary (3 shared papers)Ke Ding (3 shared papers)Dongguang Qin (2 shared papers)Yipin Lu (2 shared papers)Su Qiu (1 shared paper)Krzysztof Krajewski (1 shared paper)
- Journals
- BMC Ophthalmology (3 papers)Ophthalmology (2 papers)Journal of Medicinal Chemistry (2 papers)Molecular Cancer Therapeutics (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Guoping Wang
35 papers receiving 1.2k citations
Guoping Wang's Hit Papers
Peers
Comparison fields: 5 of 111
- Organic Chemistry 545
- Oncology 435
- Toxicology 37
- Molecular Biology 534
- Biotechnology 66
Countries citing papers authored by Guoping Wang
This map shows the geographic impact of Guoping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoping Wang more than expected).
Fields of papers citing papers by Guoping Wang
This network shows the impact of papers produced by Guoping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoping Wang. The network helps show where Guoping Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guoping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 Interaction Hit paper breakdown → | 2006 | 602 |
| 2 | 2009 | 147 | |
| 3 | 2007 | 126 | |
| 4 | 2008 | 75 | |
| 5 | 2003 | 66 | |
| 6 | 2016 | 37 | |
| 7 | 2016 | 34 | |
| 8 | 2008 | 32 | |
| 9 | 2012 | 18 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2016 | 12 | |
| 13 | 2013 | 11 | |
| 14 | 2024 | 10 | |
| 15 | 2013 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2016 | 7 | |
| 18 | 2021 | 6 | |
| 19 | 2013 | 6 | |
| 20 | 2020 | 6 |
About Guoping Wang
Guoping Wang is a scholar working on Oncology, Molecular Biology, Ophthalmology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ocular Surface and Contact Lens (3 papers), Nasolacrimal Duct Obstruction Treatments (3 papers), Cancer-related Molecular Pathways (3 papers), Mesenchymal stem cell research (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Behavioral Health and Interventions (2 papers), Immune Cell Function and Interaction (2 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Organic Chemistry (545 citations), Oncology (435 citations), Toxicology (37 citations), Molecular Biology (534 citations) and Biotechnology (66 citations). Guoping Wang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Shaomeng Wang, Zaneta Nikolovska‐Coleska, Sanjeev Shangary, Ke Ding, Dongguang Qin, Yipin Lu, Su Qiu, Krzysztof Krajewski, Wei Gao and Peter P. Roller. Their work appears in journals such as BMC Ophthalmology, Ophthalmology, Journal of Medicinal Chemistry, Molecular Cancer Therapeutics and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.